Intranasal fentanyl for pain control: current status with a focus on patient considerations

References

• PattRBBurtonAWPain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain managementEvaluation and Treatment of Chronic PainNew YorkLippincott, Williams & Wilkins1998337376
   Google Scholar
• KalsoEEdwardsJEMooreRAMcQuayHJOpioids in chronic non-cancer pain: systematic review of efficacy and safetyPain200411237238015561393
   PubMed Web of Science ®Google Scholar
• Dosen-MicovicLIvanovicMMicovicVSteric interactions and the activity of fentanyl analogs at the [mu]-opioid receptorBioorg Med Chem2006142887289516376082
   PubMed Web of Science ®Google Scholar
• ShelleyKPaechMJThe clinical applications of intranasal opioidsCurr Drug Deliv200855518220551
   PubMedGoogle Scholar
• VyasTKShahiwalaAMaratheSMisraAIntranasal drug delivery for brain targetingCurr Drug Deliv2005216517516305417
   PubMedGoogle Scholar
• DaleOHjortkjaerRKharaschEDNasal administration of opioids for pain management in adultsActa Anaesthesiol Scand20024675977012139528
   PubMed Web of Science ®Google Scholar
• BirkhoffMLeitzMMarxDAdvantages of intranasal vaccination and considerations on device selectionIndian J Pharm Sci200971729
   Web of Science ®Google Scholar
• Veldhorst-JanssenNMLFiddelersAAAvan der KuyPHMA review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasallyClin Ther2009312954298720110035
   PubMed Web of Science ®Google Scholar
• SchwagmeierROelmannTDannappelTStriebelHWPatientenakzeptanz gegennber der patientenkontrollierten intranasalen Analgesie (PCINA)Der Anaesthesist1996452312348919895
   PubMed Web of Science ®Google Scholar
• PenningtonAKRatcliffeJHWilsonCGHardyJGThe influence of solution viscosity on nasal spray deposition and clearanceInt J Pharm198843221224
   Web of Science ®Google Scholar
• IllumLJorgensenHBisgaardHBioadhesive microspheres as a potential nasal drug delivery systemInt J Pharm198739189199
   Web of Science ®Google Scholar
• Veldhorst-JanssenNMLFiddelersAAAvan der KuyPHMPharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: a prospective, randomized, double-blind, placebo-controlled studyClin Ther2010321427143620678689
   PubMed Web of Science ®Google Scholar
• PaechMJLimCBBanksSLA new formulation of nasal fentanyl spray for postoperative analgesia: a pilot studyAnaesthesia20035874074412859464
   PubMed Web of Science ®Google Scholar
• GrapeSSchugSALauerSSchugBSFormulations of fentanyl for the management of painDrugs201070577220030425
   PubMed Web of Science ®Google Scholar
• PanagiotouIMystakidouKIntranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applicationsExpert Rev Anticancer Ther2010101009102120645689
   PubMed Web of Science ®Google Scholar
• ChristrupLLFosterDPopperLDPharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover studyClin Ther20083046948118405786
   PubMed Web of Science ®Google Scholar
• FisherAWatlingMSmithAKnightAPharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188Int J Clin Pharmacol Ther20104813820137766
   PubMed Web of Science ®Google Scholar
• PrommerEThe role of fentanyl in cancer-related painJ Palliat Med20091294795419807240
   PubMed Web of Science ®Google Scholar
• PortenoyRKHagenNABreakthrough pain: definition, prevalence and characteristicsPain1990412732811697056
   PubMed Web of Science ®Google Scholar
• ColuzziPHSchwartzbergLBreakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)Pain20019112313011240084
   PubMed Web of Science ®Google Scholar
• PortenoyRKTaylorDMessinaJTremmelLA randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancerClin J Pain20062280517057563
   PubMed Web of Science ®Google Scholar
• KressHGOronskaAKaczmarekZEfficacy and tolerability of intranasal fentanyl spray 50 to 200 [mu] g for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment periodClin Ther2009311177119119695386
   PubMed Web of Science ®Google Scholar
• TaylorDGalanVWeinsteinSMFentanyl pectin nasal spray in breakthrough cancer painJ Support Oncol2010818420822038
   PubMedGoogle Scholar
• PortenoyRKRaffaeliWTorresLMLong-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patientsJ Opioid Manag2010631921046929
   PubMedGoogle Scholar
• MercadanteSRadbruchLDaviesAA comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trialCurr Med Res Opin2009252805281519792837
   PubMed Web of Science ®Google Scholar
• StriebelHWOlmannTSpiesCBrummerGPatient-controlled intranasal analgesia (PCINA) for the management of postoperative pain: a pilot studyJ Clin Anesth19968488695078
   PubMed Web of Science ®Google Scholar
• ToussaintSMaidlJSchwagmeierRStriebelHWPatient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain reliefCan J Anaesth20004729930210764171
   PubMed Web of Science ®Google Scholar
• ChristrupLLFosterDPopperLDPharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover studyClin Ther20083046948118405786
   PubMed Web of Science ®Google Scholar
• ChengXLiJHEffects of fentanyl administrated nasally and intravenously in post-operative analgesia in pediatric children: a comparative study of 36 casesZhonghua Yi Xue Za Zhi200888289819080094
   PubMedGoogle Scholar
• GalinkinJLFaziLMCuyRMUse of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesiaAnesthesiology200093137811149429
   PubMed Web of Science ®Google Scholar
• FinkelJCCohenITHannallahRSThe effect of intranasal fentanyl on the emergence characteristics after sevoflurane anesthesia in children undergoing surgery for bilateral myringotomy tube placementAnaesth Analg2001921164
   Web of Science ®Google Scholar
• VoronovPTobinMJBillingsKPostoperative pain relief in infants undergoing myringotomy and tube placement: comparison of a novel regional anesthetic block to intranasal fentanylûa pilot analysisPediatric Anesthesia2008181196120119076574
   PubMed Web of Science ®Google Scholar
• BorlandMJacobsIKingBO’BrienDA randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency departmentAnn Emerg Med20074933534017067720
   PubMed Web of Science ®Google Scholar
• BorlandMLBergesioRPascoeEMIntranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind crossover studyBurns20053183183716005154
   PubMed Web of Science ®Google Scholar
• ZeppetellaGO’DohertyCACollinsSPrevalence and characteristics of breakthrough pain in cancer patients admitted to a hospiceJ Pain Symptom Manage200020879210989246
   PubMed Web of Science ®Google Scholar
• SitteTBauseweinCIntranasal fentanyl for episodic breathlessnessJ Pain Symptom Manage.200836e318954962
   PubMedGoogle Scholar